Skip to main content

Homepage

Latest News

Researchers tackle the product-agnostic problems that plague pain drug research

When it comes to what matters most to patients, the alleviation of pain is often top of the list. But designing clinical trials for new analgesics has proven particularly troublesome, writes IMI Executive Director Pierre Meulien in this opinion piece.

/news-events/newsroom/researchers-tackle-product-agnostic-problems-plague-pain-drug-research

Algorithmic advances, triage models and getting the ethical all-clear: IMI's COVID-19 diagnostic projects are making progress

Algorithmic advances, triage models and getting the ethical all-clear: IMI's COVID-19 diagnostic projects are making progress  more

Treatment tracker: COVID-19 therapeutics research makes progress

Treatment tracker: COVID-19 therapeutics research makes progress  more

An open letter in response to the GHA/CEO report on IMI

An open letter in response to the GHA/CEO report on IMI  more

 

 

IMI – radical collaboration in action

A new brochure, 'IMI - radical collaboration in action', showcases some recent IMI project successes, which include an approved vaccine for Ebola, insights into the genetics of Alzheimer’s disease, a new classification of diabetes, and advances on using liquid biopsies for cancer, as well as contributions to the fight against COVID-19.

 more

dna.jpg

 

 

 

IMI covid-19 response

 

Within weeks of the first reports of coronavirus in Europe, IMI launched a fast-track Call for proposals to develop therapeutics and diagnostics for current and future coronavirus outbreaks

 

ddd